March 6, 2024 — Bodyport Inc., a biomarker-guided predictive care company focused on heart failure, announced data from a late-breaking presentation showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care.
